Pro-Israel Lobby AIPAC Ends Direct Candidate Endorsements for US Congress
Translated & summarized from Hamal by baba
The pro-Israel lobby AIPAC announced it will stop directly endorsing and funding candidates for the US Congress via its PAC. The organization will continue to influence elections through its Super PAC, the United Democracy Project. This change occurs amidst growing criticism of candidates receiving pro-Israel financial support.
The story in 4 lines · by baba
- AIPAC will no longer directly endorse or fund US Congress candidates through its PAC.
- The lobby will continue to influence elections via its Super PAC, the United Democracy Project.
- The decision follows three election cycles of direct candidate support by AIPAC.
- The move comes amid increasing criticism of candidates receiving pro-Israel funding.
The pro-Israel lobby AIPAC announced Thursday it will cease officially endorsing and directly funding candidates running for the US Congress through its Political Action Committee (AIPAC PAC). This decision follows three election cycles where the organization was directly involved in supporting candidates and fundraising for them.
AIPAC clarified that it will continue its political engagement and fundraising efforts through other avenues. Notably, it will still utilize its influential Super PAC, the United Democracy Project, which has already invested tens of millions of dollars in congressional election campaigns.
The shift in strategy comes amid mounting criticism directed at candidates who receive financial backing from pro-Israel organizations. AIPAC's move signals a change in how it will operate within the American political landscape, moving away from direct candidate support while maintaining significant financial influence.
The same event, reported separately by each outlet. Open a few to compare what different newsrooms emphasize — and what they leave out.
Left 1Centre 6Right 3Haredi 1Other 1
Not the same event — other stories that share this one’s people, places, or theme: background, reactions, and follow-ups.
